This inventor holds 3 USPTO granted patents. Top assignee: Genzyme Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ryan Hartung: Innovator in Pharmaceutical Compounds
Introduction
Ryan Hartung is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating diseases related to cystic fibrosis. With a total of 3 patents to his name, Hartung's work is recognized for its potential impact on medical treatments.
Latest Patents
Hartung's latest patents include innovative compounds known as Arylamides. The first patent discusses heterocyclic compounds and their pharmaceutically acceptable salts, along with pharmaceutical preparations. This disclosure emphasizes the use of these compounds in treating diseases mediated by deficient CFTR activity, specifically targeting cystic fibrosis. The second patent also focuses on substituted aryl amide compounds, detailing their formula and applications in similar medical contexts.
Career Highlights
Ryan Hartung is currently employed at Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Hartung has collaborated with esteemed colleagues, including Zhongli Gao and Hans Peter Nestler. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Ryan Hartung's contributions to pharmaceutical innovations, particularly in the area of cystic fibrosis treatment, highlight his role as a significant inventor in the field. His ongoing work at Genzyme Corporation continues to pave the way for advancements in medical therapies.